CORO1A

Across TCGA pan-cancer cohorts, CORO1A Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated CORO1A data layer compared with 24 for mass-spec protein and 7 for mass-spec protein.

The strongest signal is observed in small cell lung cancer (SCLC), where higher CORO1A Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated CORO1A expression acts as an unfavorable survival marker.

SCLC and STAD are the cancer types where CORO1A Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SCLC	DFS	Median	III,IV	0.137	0.546	.042	6	view →
STAD	OS	Median	III,IV	0.423	0.634	.002	4	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

CORO1A–SCLC (DFS)

Open the SCLC breakdown →